Nulibry 9.5 mg lyophilized powder for injection Images
Generic Name: fosdenopterin
This medication has been identified as Nulibry 9.5 mg lyophilized powder for injection. It is supplied by Sentynl Therapeutics, Inc.
Nulibry is used in the treatment of Molybdenum Cofactor Deficiency Type A and belongs to the drug class miscellaneous metabolic agents. Nulibry 9.5 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Nulibry
- Generic Name
- fosdenopterin
- Strength
- 9.5 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sentynl Therapeutics, Inc.
- Manufacturer
- Alcami Carolinas Corporation
- National Drug Code (NDC)
- 73129-0001 (Discontinued)
See also:
More about Nulibry (fosdenopterin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.